Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
1,799,585
-
Share change
-
+1,799,585
-
Total reported value
-
$4,384,000
-
Price per share
-
$2.52
-
Number of holders
-
15
-
Value change
-
+$4,384,000
-
Number of buys
-
15
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q2 2019
As of 30 Jun 2019,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,799,585 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, PERCEPTIVE ADVISORS LLC, CSS LLC/IL, Birchview Capital, LP, BRIDGEWAY CAPITAL MANAGEMENT INC, STATE STREET CORP, MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.